To Promote and Implement
Safe Medication Practices
In Israel, Through
Education and Research
ISOP ISRAEL is an
Innovative and Multidisciplinary Platform
To Share Experience, Expertise, and Knowledge
To Design Technologic and Methodologic Solutions
For All Stakeholders
Up to 77% of all adverse drug reactions can be prevented!
Yet, they remain the
4th to 5th leading causes of death
in Western countries
ISOP ISRAEL ANSWER
Innovative Tools and Methods
Multidisciplinary Integrated Strategies
Meetings, Summits and Workshops Program
PROGRAM AT A GLANCE
END OF THE
HOT SUMMER IN DRUG SAFETY
Coming back in September
INDIAN SUMMER IN DRUG SAFETY
28 July POSTPONED TO Q4, 2020
Foetal and maternal exposure Prof Gideon Koren
Case retrieved with AI Dr. Gidi Stein English
Record of the 8 July Session
Tell us a safety case story
DOACs and drug interactions. Prof Ronen Loebstein
Can we prevent Lyell and Steven-Johnson syndromes
Dr Irene Fermont
All recordings of the Hot Summer sessions will be soon available
Healthcare professionals: physicians, general practitioners and specialists, pharmacists, clinical pharmacologists, clinical pharmacists, nurses
Pharmacovigilance staff from Hospital, Industry and Kupot Kholim.
Risk managers in Hospital and Industry
Patient Safety ,Quality of Care managers
Head of medical departments (cardiology, internal medicine,pneumology, haematology, surgery, neurology, oncology...).
Industry medical directors and regulatory affairs staff
Health funds and insurance, Kupot Kholim.
Patients and patients’ associations.
Ministry of Health: Pharmacovigilance, Patient safety.